883TiP MOONSTONE/GOG-3032: A phase II, open-label, single-arm study to evaluate the efficacy and safety of niraparib + dostarlimab in patients with platinum-resistant ovarian cancer

Authors :: Robert L. Coleman
Angeles Alvarez Secord
S. Adams
S. Arora
F. Cappuccini
E. Keeton
Bradley J. Monk
H.S. Chon
Divya Gupta
Stephanie Gaillard
Roisin E. O'Cearbhaill
David M. O'Malley
Panagiotis A. Konstantinopoulos
V. Samnotra
Marilyn Huang
Leslie M Randall
Source :: Annals of Oncology. 31:S646-S647
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Hematology
medicine.disease
Internal medicine
medicine
In patient
Open label
Moonstone
business
Ovarian cancer
Single Arm Study
Platinum resistant

Full Text Access

Tools